Blue Horseshoe Stocks: JNUG, RAMO & More

Direxion Daily Jr Gld Mnrs Bull 3X ETF (JNUG)

We’ve been tracking JNUG in the wake of last week’s annual low on the price of gold, and as the price of the precious metal has rebounded it has provided us with a few swing-trade opportunities.

Initially we saw JNUG run from 3.59-4.44 (+24%), and after pulling back slightly to 3.65 yesterday morning, the ETF ran back to 4.40, an intraday increase of 20% on several times the average trading volume.

We expect to witness similar patterns of activity in JNUG as long as the price of gold continues to rebound. We’re looking for it to hold support at or above $1161 (Trading in $1166-range this morning)


Ramoil Management Ltd. RAMO

We want to tag RAMO this morning and add it to our list of cannabis-related stocks; according to a PR we just caught coming over the wires, the company is set to begin clinical testing with both CBD and THC (chemical compounds found in marijuana).

It is conveniently timed with the “major hurdle” that was just cleared with regard to government approval of using cannabis for the treatment of soldiers diagnosed with PTSD. The U.S. Department of Health & Human Services has given its stamp of approval, with the measure only needing DEA clearance before becoming policy. >> Read Article in US Today

LAS VEGAS, Nov. 12, 2014 /PRNewswire/ — RAMOIL MANAGEMENT, Ltd (RAMO) wants to honor and support our veterans by announcing that RAMO Bio-Med, Inc., its wholly owned subsidiary, is beginning with controlled clinical testing of “RAMO CBD” and “RAMO THC” formulas for the treatment of Post Traumatic Stress Disorder, commonly known as PTSD. >> Full PR


Dendreon Corp. DNDN

We’ve been watching DNDN for a bounce opportunity this week, as the stock has been way oversold of late. This morning it appears as if the stock is trying to gap up slightly, so we just want to throw in a reminder that this stock could turn into a hefty bounceplay at any time.


Extended Watchlist:
SWET(News), GEVO, RADA, SUPN, SUSQ, CGG